J. H. Beijnen

Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.

B.G. Taal, Cornelis A. Hoefnagel, R.A. Valdés Olmos et al. · Journal of Clinical Oncology · 1996 · 123 citations

Medicine, Oncology, Pharmacology +14

Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks

L.J.C. van Warmerdam, Jaap Verweij, Jan H.M. Schellens et al. · Cancer Chemotherapy and Pharmacology · 1995 · 94 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +9

DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update

Linda M. Henricks, Frans L. Opdam, J. H. Beijnen et al. · Annals of Oncology · 2017 · 93 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives (review).

Olaf van Tellingen, Jan H. M. Sips, J. H. Beijnen et al. · PubMed · 1992 · 52 citations

Medicine, Pharmacokinetics, Pharmacology +12

Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb

JM Klaase, B.B.R. Kroon, J. H. Beijnen et al. · British Journal of Cancer · 1994 · 51 citations · Full text

Medicine, Oncology, Surgery +14